Department of Internal Medicine University Hospital Motol 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Pediatric Neurology Thomayer University Hospital Prague Czech Republic

Zobrazit více v PubMed

Brož, J., Janíčková Žďárská, D., Urbanová, J., Brabec, M., Doničová, V., Štěpánová, R., Martinka, M., & Kvapil, M. (2018). Current level of glycemic control and clinical inertia in subjects using insulin for the treatment of type 1 and type 2 diabetes in The Czech Republic and the Slovak Republic: Results of a multinational, multicenter, observational survey (DIAINFORM). Diabetes Therapy, 9(5), 1897–1906. https://doi.org/10.1007/s13300‐018‐0485‐2

Gerstein, H. C., Miller, M. E., Byington, R. P., Goff, D. C., Bigger, T., Buse, J. B., Cushman, W. C., Genuth, S., Ismail‐Beigi, F., Grimm, R. H., Probstfield, J. L., Simons‐Morton, D. G., & Friedewaldet, W. T. (2008). Effects of intensive glucose lowering in type 2 diabetes. The New England Journal of Medicine, 358(24), 2545–2559.

Lin, Y. K., Hung, M., Sharma, A., Chan, O., Varner, M. W., Staskus, G., & Fisher, S. J. (2019). Impaired awareness of hypoglycemia continues to be a risk factors for severe hypoglycemia despite the use of continuous glucose monitoring systems in type 1 diabetes. Endocrine Practice, 25(6), 517–525. https://doi.org/10.4158/EP‐2018‐0527

Sönmez Sari, E., Semerci Çakmak, V., Çetinkaya Özdemir, S., & Eşsiz Sefer, B. (2024). Hypoglycaemic confidence levels and experiences related to the hypoglycaemia of patients with diabetes: A mixed methods study. The Journal of Clinical Nursing, 33(3), 1022–1035. https://doi.org/10.1111/jocn.17038

Wright, A. D., Cull, C. A., Macleod, K. M., Holman, R. R., & UKPDS Group. (2006). Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73. The Journal of Diabetes Complications, 20(6), 395–401.